Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrm LE, Ueland PM, Palma-Reis RJ, Boers GHJ, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, De Valk HW, Lis ACS, Parrot-Roulaud FM, Tan KS, Higgins I, and Garcon D (1997)
The mean (+SD) BPC157 plasma concentration versus time curves following administration of various BPC157 doses in dogs are shown in Figures 2AC, and the corresponding pharmacokinetic parameters are presented in Tables 4Tables 6
In the CVB3-CP17 structure, CP17 sits upright in the interprotomer pocket due to stacking interactions against Phe76 of VP1 and Phe236 of VP3 from CVB3 29
Maintain sterile handling practices after first puncture